APA (7th ed.) Citation

M, U., RB, H., R, K., A, G., H, L., I, O., . . . J, A. (2026). Gut microbiome is associated with recurrence-free survival in patients with resected high-risk melanoma receiving adjuvant immune checkpoint blockade. Cell, 189(13), 3940. https://doi.org/10.1016/j.cell.2026.03.041

Chicago Style (17th ed.) Citation

M, Usyk, Hayes RB, Knight R, Gonzalez A, Li H, Osman I, Weber JS, and Ahn J. "Gut Microbiome Is Associated with Recurrence-free Survival in Patients with Resected High-risk Melanoma Receiving Adjuvant Immune Checkpoint Blockade." Cell 189, no. 13 (2026): 3940. https://doi.org/10.1016/j.cell.2026.03.041.

MLA (9th ed.) Citation

M, Usyk, et al. "Gut Microbiome Is Associated with Recurrence-free Survival in Patients with Resected High-risk Melanoma Receiving Adjuvant Immune Checkpoint Blockade." Cell, vol. 189, no. 13, 2026, p. 3940, https://doi.org/10.1016/j.cell.2026.03.041.